Skip to main content
Premium Trial:

Request an Annual Quote

Glaxo Subscribes to Gene Logic s GeneExpress Suite; Firms to Co-Develop New Database

NEW YORK, Dec. 10 - Gene Logic said on Monday that GlaxoSmithKline has subscribed to its GeneExpress suite for an undislosed number of years, and will parter to create a new tissue database, the bioinformatics company said on Monday.


Terms of the deal call for the UK-based drug giant to access Gene Logic's BioExpress module, the largest data subset of the company's GeneExpress kit. In addition, the new database they plan to co-develop will contain segments of Glaxo's in-house data, which will be fully integrated with data from BioExpress.


Gene Logics' GeneExpress kit comprises gene expression and associated clinical information from tissues culled from normal and diseased human samples, model animal systems, and human and animal cell lines.


Terms of the deal were not disclosed.


"We look forward to providing enabling information products, based on our gene expression database, to help support [GlaxoSmithKline's] ongoing drug development and target discovery efforts," Mark D. Gessler, chairman and CEO of Gene Logic said.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.